Back

MXCT

-5.00%
NEUTRAL

MaxCyte Announces Change in Substantial Shareholding

Why we think this is neutral

This RNS announcement does not contain any of the mandatory news types that would require a more detailed analysis. It simply reports a change in substantial shareholding by BlackRock, Inc. Without any financial or operational updates, the sentiment is neutral.

Key Points

  • BlackRock, Inc. now holds 10.14% of MaxCyte's voting rights

Summary

The healthcare company reports a change in substantial shareholding by BlackRock, Inc.

MaxCyte, Inc., a medical devices company, has announced a change in substantial shareholding. BlackRock, Inc. now holds 10.14% of the company's voting rights, up from 9.98% previously.

DIRECTOR DEALINGS